Abstract
We report a case of a 62 year-old patient who developed Palmar-plantar erythrodysesthesia upon receiving four cycles of capacitabine-based chemotherapy. She was on post surgical adjuvant treatment for invasive well differentiated adenocarcinoma of the colon. The clinical and therapeutic aspects of this chemotherapeutic adverse effect are discussed.
Keywords:
Kenya; Palmar-plantar erythrodysesthesia; capecitabine.
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / pathology
-
Antimetabolites, Antineoplastic / adverse effects*
-
Antimetabolites, Antineoplastic / therapeutic use
-
Capecitabine / adverse effects*
-
Capecitabine / therapeutic use
-
Colonic Neoplasms / drug therapy
-
Colonic Neoplasms / pathology
-
Female
-
Hand-Foot Syndrome / etiology*
-
Hand-Foot Syndrome / pathology
-
Humans
-
Middle Aged
Substances
-
Antimetabolites, Antineoplastic
-
Capecitabine